208 related articles for article (PubMed ID: 6277363)
1. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
Lee JN; Salem HT; Chard T; Huang SC; Ouyang PC
Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
[TBL] [Abstract][Full Text] [Related]
2. Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases.
Than GN; Bohn H; Csaba IF; Szabó DG; Karg NJ; Göcze P
Arch Gynecol; 1981; 231(1):33-9. PubMed ID: 6174083
[TBL] [Abstract][Full Text] [Related]
3. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
6. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
[TBL] [Abstract][Full Text] [Related]
7. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the new placental proteins in trophoblastic disease.
Tsakok FH; Koh S; Chua SE; Ratnam SS; Teisner B; Jones GR; Sinosich M; Grudzinskas JG
Br J Obstet Gynaecol; 1983 May; 90(5):483-6. PubMed ID: 6189512
[TBL] [Abstract][Full Text] [Related]
9. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
Sakuragi N
Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
[No Abstract] [Full Text] [Related]
10. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
Rutanen EM; Seppälä M
J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
[No Abstract] [Full Text] [Related]
12. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
Radikov N
Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
[TBL] [Abstract][Full Text] [Related]
13. Serum prolactin levels and immunohistochemical localization of prolactin in trophoblastic disease.
Ranta T; Wahlström T; Rutanen EM; Stenman UH; Seppälä M
Acta Pathol Microbiol Scand A; 1981 May; 89(3):235-9. PubMed ID: 6274140
[TBL] [Abstract][Full Text] [Related]
14. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast.
Seppälä M; Wahlström T; Bohn H
Int J Cancer; 1979 Jul; 24(1):6-10. PubMed ID: 225283
[No Abstract] [Full Text] [Related]
16. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of SP1 and beta-hCG in serum and cerebrospinal fluid and concentrations of hCG in urine in patients with trophoblastic tumour.
Soma H; Kikuchi K; Takayama M; Saegusa H; Saito T; Kashiwagi H; Sayama S
Arch Gynecol; 1981; 230(4):321-7. PubMed ID: 6269502
[TBL] [Abstract][Full Text] [Related]
18. Schwangerschaftsprotein 1 (SP1) in serum and cerebrospinal fluid of patients with gestational trophoblastic disease.
Ho PC; Ma HK
Br J Obstet Gynaecol; 1983 Apr; 90(4):317-22. PubMed ID: 6188478
[TBL] [Abstract][Full Text] [Related]
19. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
Seki K; Uesato T; Kato K
Endocrinol Jpn; 1986 Oct; 33(5):727-33. PubMed ID: 3030714
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
